401sek
-1,2 %
Date:2026-01-12Time:17:24:41Latest report:Q2-2025List:First NorthTicker:NANEXA
Market Cap:635 msekEnterprise Value:632 msekNet Sales:14,3 msekEarnings:-37,6 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:4,05
MA50:2,46
MA200:2,12
Price/MA200:91,5 %
RSI (14):68,5
Price/MA50:64,6 %

Description

Nanexa is a drug delivery company with a proprietary platform used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The company's technology is based on encapsulating drug particles with a thin shell and creating opportunities for pharmaceutical companies to develop new products. Nanexa has collaborations with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment